There is a question that seems almost impolite to ask about medicine:
What if the tools are wrong?
Not the surgeons. Not the training. Not the dedication or the intelligence or the years of practice that go into becoming someone who can hold a life in their hands and steady it.
The tools. The physical instruments. The fundamental mechanics of how surgery is performed on a human body.
Catherine Mohr asked that question. And the answer she arrived at changed what surgery looks like for millions of people who will never know her name.
Mohr came to medicine from the outside — from mechanical engineering, from a professional world governed by physics and mathematics and the unforgiving principle that a system either performs to specification or it doesn’t.
In that world, when a design has limitations, you don’t celebrate the limitations as tradition. You identify them, study them, and engineer your way around them.
When she turned that analytical attention toward surgery, what she saw was this:
Human hands — even the steadiest, most skilled, most brilliantly trained surgical hands in the world — tremble. Microscopically, involuntarily, physiologically. It is not weakness. It is biology.
Human wrists rotate and bend only within the ranges that bone and connective tissue allow. They cannot articulate at the angles that internal anatomy sometimes demands for optimal surgical access.
Incisions have to be made large enough to accommodate human hands and forearms — far larger, in many cases, than the actual surgical work requires — simply because there is no other way to get skilled human hands to the place they need to be.
Surgeons were extraordinary. Their tools were, by engineering standards, primitive.
The question Mohr and a growing community of engineers and surgeons began asking in the late 1980s and 1990s was direct: what if you could extend the surgeon’s capabilities past what human anatomy allows?
Not replace the surgeon. Not remove judgment or skill or the irreplaceable human relationship between physician and patient.
Extend it. Give the surgeon’s expertise a more precise physical expression than bare hands inside a body cavity could provide.
The development of what became the da Vinci Surgical System was a collaborative effort across years and institutions — DARPA-funded research, work at SRI International, the founding vision of engineers like Frederic Moll, and the contributions of dozens of researchers, physicians, and engineers who each brought something essential to a problem that no single person could solve alone.
Catherine Mohr was part of that effort at Intuitive Surgical — contributing to the development, testing, and refinement of systems that would need to earn the trust of a medical establishment deeply and reasonably skeptical of machines in operating rooms.
That skepticism was not irrational. It was responsible.
Surgery is intimate. Tactile. The haptic feedback of feeling tissue resistance with your own hands is real clinical information. The concerns about mechanical failure, software errors, loss of power during critical procedures — these were legitimate questions requiring rigorous answers, not obstacles to be dismissed.
The answer was data.
Clinical outcomes. Controlled studies. Peer-reviewed research accumulated over years, procedure by procedure, specialty by specialty, showing measurable improvement in the things that matter most to patients: blood loss, recovery time, post-operative pain, complication rates, time before returning to normal life.
What the technology delivered was a transformation in the mechanics of surgery itself.
Robotic instruments — tiny, far smaller than human fingers — could rotate through seven degrees of freedom, articulating at angles a human wrist cannot achieve. Involuntary tremors were filtered algorithmically, translated into perfectly smooth movements. The surgical field was magnified and rendered in high-definition three-dimensional imaging, giving surgeons a view of their work dramatically superior to what the naked eye could see through a traditional incision.
Surgeons operated from an ergonomic console, their natural hand movements translated in real time into precise, scaled motions inside the patient’s body. The learning curve was real but manageable — the system was designed to work with surgeons’ existing motor skills, not demand they develop entirely new ones.
Incisions that once had to be 15 to 30 centimeters to accommodate human hands could become 1 to 2 centimeters. Recoveries that took 6 to 8 weeks from major open surgery became days.
The resistance from the medical establishment did not vanish overnight — it never does, and it shouldn’t. Medicine changes slowly because the cost of being wrong is paid by patients. But the evidence accumulated until it was impossible to responsibly ignore.
Today, robotic-assisted surgery is a standard of care across cardiac, urological, gynecological, thoracic, colorectal, and dozens of other surgical specialties worldwide. Millions of procedures are performed every year using systems built on principles that a generation ago seemed like science fiction to most of the surgeons now using them routinely.
Patients leave hospitals in days. Scars are barely visible. Pain is substantially reduced. Lives that would have required months of recovery return to normal in weeks.
The people who benefited from this transformation will mostly never know the names of the engineers who made it possible — not Mohr, not Moll, not the researchers at SRI International, not the dozens of others who contributed essential pieces to a puzzle that took decades to complete.
They will know only the faster healing. The smaller scar. The afternoon they felt well enough to sit outside and watch their children play, weeks sooner than the surgery they needed once would have allowed.
Catherine Mohr has spent years not only contributing to surgical robotics but explaining it — making the case to medical communities, to patients, to anyone willing to listen, for why questioning whether a tool is optimal is not disrespect for the people who use it but respect for the patients who depend on it.
She understood something that takes genuine intellectual courage to hold onto in the face of institutional resistance:
Tradition and optimality are not the same thing.
A practice can be respected, long-established, performed by brilliant and dedicated people — and still have room for improvement. The two things are not in conflict. The willingness to ask whether we can do better is not a criticism of everyone who came before. It is the continuation of the same commitment to patient welfare that motivated every surgeon who came before.
The operating room looked different to Catherine Mohr than it did to most people who walked into it.
She saw, alongside the skill and the dedication and the years of training, a mechanical problem. A gap between what surgeons needed to accomplish and what human hands could physically provide.
She spent her career helping to close that gap.
Millions of people healed faster because she did.
That’s not just engineering. That’s what engineering is for.
